-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Entrada Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2021 to Q1 2025.
- Entrada Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$38.5M, a 50.9% decline year-over-year.
- Entrada Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$41.6M, a 130% decline from 2023.
- Entrada Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $140M.
- Entrada Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$93.8M, a 84.4% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)